Frustration from patients at lack of information in Alzheimer’s risk biomarker results

As researchers in Alzheimer’s turn their focus away from treating the disease after diagnosis and begin to look at preventative measures, a study at the Perelman School of Medicine at the University of Pennsylvania (PA, USA) has examined responses from seniors when given brain scan results detailing amyloid levels. Developing a preventative therapy is challenging for a number of reasons; however, it will require the identifying and informing individuals with high Alzheimer’s risk in order to test potential new therapies. The study examined cognitively normal seniors of 65 years and older who had been accepted into a large Alzheimer’s prevention...